since 1980, medifast, inc.(nyse: med) has been a brand recommended by 20,000 doctors. developed by a physician, medifast is a clinically proven nutrition and weight loss company based in maryland. we change lives by producing results and helping those succeed. because everyone has different goals and ways of learning, we offer several support programs as you choose health with medifast. we believe that healthier people are happier people. everyone has the right to feel good about themselves. our vision is to create a world where it's easy to take control of your own well-being. we're on a mission to empower people with the right opportunities to enjoy the healthy life they deserve. we see it every day. the ear-to-ear grin. the “holding back the tears” pride. the glow of pure joy when someone reaches their weight-loss goals. their whole life gets better, and so does yours, because you helped them get there. if you’d like to spend every day helping to change people’s lives for the better
Company profile
Ticker
MED
Exchange
Website
CEO
Daniel Chard
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
HEALTHRITE INC
SEC CIK
Corporate docs
Subsidiaries
Corporate Events, Inc. • Jason Enterprises, Inc. • Jason Pharmaceuticals, Inc. • Jason Properties, LLC • OPTAVIA LLC • OPTAVIA Health Consultation (Shanghai) Co., Ltd. • OPTAVIA (Hong Kong) Limited • OPTAVIA (Singapore) PTE. LTD • Seven Crondall Associates, LLC ...
IRS number
133714405
MED stock data
Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
8 May 24
10-Q
2024 Q1
Quarterly report
29 Apr 24
8-K
Medifast Announces First Quarter 2024 Financial Results
29 Apr 24
DEFA14A
Additional proxy soliciting materials
26 Apr 24
DEF 14A
Definitive proxy
26 Apr 24
8-K
Medifast Announces Fourth Quarter and Full Year 2023 Financial Results
20 Feb 24
10-K
2023 FY
Annual report
20 Feb 24
8-K
Other Events
13 Dec 23
10-Q
2023 Q3
Quarterly report
6 Nov 23
8-K
Medifast Announces Third Quarter 2023 Financial Results
6 Nov 23
Transcripts
MED
Earnings call transcript
2023 Q4
20 Feb 24
MED
Earnings call transcript
2023 Q3
6 Nov 23
MED
Earnings call transcript
2023 Q2
7 Aug 23
MED
Earnings call transcript
2023 Q1
1 May 23
MED
Earnings call transcript
2022 Q4
21 Feb 23
MED
Earnings call transcript
2022 Q3
4 Nov 22
MED
Earnings call transcript
2022 Q2
4 Aug 22
MED
Earnings call transcript
2022 Q1
3 May 22
MED
Earnings call transcript
2021 Q4
24 Feb 22
MED
Earnings call transcript
2021 Q3
5 Nov 21
Latest ownership filings
4
James P. Maloney
19 Mar 24
4
Jonathan Barrett MacKenzie
19 Mar 24
4
Daniel R Chard
19 Mar 24
4
James P. Maloney
15 Mar 24
4
Jonathan Barrett MacKenzie
15 Mar 24
4
Daniel R Chard
15 Mar 24
4
SCOTT SCHLACKMAN
12 Mar 24
144
Notice of proposed sale of securities
8 Mar 24
4
Daniel R Chard
16 Feb 24
4
James P. Maloney
16 Feb 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 112.75 mm | 112.75 mm | 112.75 mm | 112.75 mm | 112.75 mm | 112.75 mm |
Cash burn (monthly) | 11.55 mm | (no burn) | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 85.02 mm | n/a | n/a | n/a | n/a | n/a |
Cash remaining | 27.73 mm | n/a | n/a | n/a | n/a | n/a |
Runway (months of cash) | 2.4 | n/a | n/a | n/a | n/a | n/a |
Institutional ownership, Q4 2023
6.6% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 31 |
Opened positions | 6 |
Closed positions | 198 |
Increased positions | 9 |
Reduced positions | 10 |
13F shares | Current |
---|---|
Total value | 45.69 bn |
Total shares | 721.18 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Pacer Advisors | 522.73 k | $35.14 bn |
Nordea Investment Management Ab | 47.77 k | $3.20 bn |
Denali Advisors | 21.81 k | $1.47 bn |
Values First Advisors | 21.25 k | $1.43 bn |
New York State Teachers Retirement System | 19.29 k | $1.30 mm |
Exchange Traded Concepts | 18.67 k | $1.25 bn |
Allspring Global Investments | 12.28 k | $825.66 mm |
Meeder Asset Management | 11.18 k | $751.79 mm |
DekaBank Deutsche Girozentrale | 7.93 k | $536.00 k |
SG Americas Securities | 7.27 k | $488.00 k |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Mar 24 | Jonathan Barrett MacKenzie | Common Stock | Payment of exercise | Dispose F | No | No | 36.61 | 83 | 3.04 k | 3,917 |
15 Mar 24 | Jonathan Barrett MacKenzie | Common Stock | Payment of exercise | Dispose F | No | No | 36.61 | 51 | 1.87 k | 4,000 |
15 Mar 24 | Maloney James P. | Common Stock | Payment of exercise | Dispose F | No | No | 36.61 | 424 | 15.52 k | 19,534 |
15 Mar 24 | Maloney James P. | Common Stock | Payment of exercise | Dispose F | No | No | 36.61 | 119 | 4.36 k | 19,958 |
15 Mar 24 | Maloney James P. | Common Stock | Payment of exercise | Dispose F | No | No | 36.61 | 73 | 2.67 k | 20,077 |
15 Mar 24 | Chard Daniel R | Common Stock | Payment of exercise | Dispose F | No | No | 36.61 | 1,859 | 68.06 k | 99,821 |
15 Mar 24 | Chard Daniel R | Common Stock | Payment of exercise | Dispose F | No | No | 36.61 | 942 | 34.49 k | 101,680 |
15 Mar 24 | Chard Daniel R | Common Stock | Payment of exercise | Dispose F | No | No | 36.61 | 608 | 22.26 k | 102,622 |
13 Mar 24 | Chard Daniel R | Common Stock | Grant | Acquire A | No | No | 0 | 45,087 | 0.00 | 103,230 |
13 Mar 24 | Maloney James P. | Common Stock | Grant | Acquire A | No | No | 0 | 8,718 | 0.00 | 20,150 |
News
Top 4 Defensive Stocks You'll Regret Missing This Quarter
2 May 24
Gold Down Over 2%; 3M Profit Beats Expectations
30 Apr 24
Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
30 Apr 24
DA Davidson Maintains Neutral on Medifast, Lowers Price Target to $25
30 Apr 24
Nasdaq Dips Over 100 Points; Coca-Cola Earnings Top Views
30 Apr 24